Evarrest FDA Approval History
FDA Approved: Yes (First approved December 5, 2012)
Brand name: Evarrest
Generic name: fibrin sealant
Dosage form: Patch
Company: Ethicon, Inc.
Treatment for: Bleeding Disorder
Evarrest (fibrin sealant patch) is indicated for use with manual compression as an adjunct to hemostasis for problematic soft tissue bleeding during surgery.
Development Timeline for Evarrest
|Dec 7, 2012||Approval FDA Approves Evarrest Fibrin Sealant Patch|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.